This review summarizes the development and preliminary human trial results of transcatheter mitral valve replacement devices.
Answers are grounded in this paper and cite their sources.
Early TMVR results remain preliminary; leaves open the need for larger randomized trials before clinical use.
As transcatheter aortic valve replacement (TAVR) has become routine, device manufacturers and investigational cardiologists have set their sights on the mitral valve. Although transcatheter mitral valve replacement (TMVR) poses several technical challenges, they appear to be surmountable, and work is proceeding. Here we review the various devices being developed and preliminary results of trials in humans.
No takes yet. Share an insight, caveat, or question.
Krishnaswamy et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: